Skip to main content
Article thumbnail
Location of Repository

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH

By Stine H Kresse, Magne Skårn, Hege O Ohnstad, Heidi M Namløs, Bodil Bjerkehagen, Ola Myklebost and Leonardo A Meza-Zepeda
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1986). A: Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms.
    2. (2002). A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
    3. (1995). AG: Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer
    4. (2003). Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    5. (2004). Bieche I: Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RTPCR. Mol Cancer
    6. (2005). Borresen-Dale AL: CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics
    7. (2006). Coukos G: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA
    8. (2006). Croce CM: MicroRNA expression and function in cancer. Trends Mol Med
    9. (2006). Croce CM: MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene
    10. (2007). Csiszar K: Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer
    11. (1995). Cytogenetic findings in malignant peripheral nerve sheath tumors.
    12. (2007). Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxiainduced transcription profile signifies metastatic potential. BMC genomics
    13. (1999). Epidemiology of neurofibromatosis type 1.
    14. (2004). Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. Carcinogenesis
    15. (2006). F: Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.
    16. (2002). Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    17. (2000). Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett
    18. (1999). Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer
    19. (2006). Gronchi A: Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer
    20. (2006). H: cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
    21. (2000). H: Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    22. HJ: Survival data for patients with malignant schwannoma.
    23. (2005). INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res
    24. (1996). Kallioniemi OP: Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res
    25. (1999). Lothe RA: Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer
    26. (2003). Lothe RA: Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
    27. (2003). Lysyl oxidaserelated protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res
    28. (2006). Myklebost O: Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res
    29. (2004). Myklebost O: M-CGH: analysing microarray-based CGH experiments. BMC bioinformatics
    30. (1996). Pathology of the major peripheral nerve sheath neoplasms. Monogr Pathol
    31. (2006). Pelus LM: Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther
    32. (2004). Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study.
    33. (1999). S: Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer
    34. (2003). S: p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Clin Cancer Res
    35. (2001). Significance analysis of microarrays applied to the ionizing radiation response.
    36. (2007). Survivin expression levels as independent predictors of survival for osteosarcoma patients.
    37. (2006). T: Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization. Oncol Rep
    38. (2007). VF: Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.